Intra-operative Detection of Positive Margins in Breast Surgery
NCT06977698 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-05-18
Summary
In this project, we will develop a unique OCT-Raman system based on a selective sampling approach optimised for high-resolution analysis of whole lumpectomy specimens. The aim of using OCT is not to detect the cancer but to identify the adipose tissue, such that the large adipose tissue regions are excluded from any further measurements by Raman spectroscopy.
While OCT has a limited ability to distinguish between tumour and surrounding normal stroma, adipose tissue has a distinctive appearance in the OCT images due to low backscattering within adipose cells (filled with lipids and small/flattened nuclei) compared to the highly scattering benign dense tissue (stroma, ducts and lobules) and malignant tissue. Such specific patterns allow identification of normal adipose tissue from breast tissue (classification models based on reflectivity profiles) with 94% sensitivity and 93% specificity. This will reduce the task of Raman measurements, which can be focused on the smaller remaining regions to discriminate between the benign and malignant tissue. This flexible and adaptable scanning strategy will achieve a much-improved diagnosis accuracy and speed to cover all surgical margins within practical timescales.
Conditions
- Breast Cancer Invasive
Interventions
- DIAGNOSTIC_TEST
-
OCT-Raman
a machine to detect positive margins in lumpectomy specimens
Sponsors & Collaborators
-
University of Nottingham
lead OTHER
Principal Investigators
-
Ioan Notingher · University of Nottingham
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2027-04-01
- Completion
- 2027-04-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Treatment
NCT06394050 ·Status: NOT_YET_RECRUITING
-
Contrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196 ·Status: ACTIVE_NOT_RECRUITING
-
Real Time Optical Coherence Tomography (OCT) of Human Tissue
NCT01506700 ·Status: TERMINATED
-
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631 ·Status: COMPLETED ·Phase: NA
-
Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
NCT00625417 ·Status: COMPLETED ·Phase: NA
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
NCT00214292 ·Status: COMPLETED ·Phase: NA
-
Using Diagnostic Tools to Stage Breast Cancer
NCT00367666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.
NCT04242277 ·Status: COMPLETED
-
A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy
NCT00788489 ·Status: COMPLETED
-
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
NCT00734838 ·Status: COMPLETED ·Phase: NA
-
LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens
NCT02037269 ·Status: COMPLETED
-
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
NCT06713681 ·Status: COMPLETED
-
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
NCT02313116 ·Status: SUSPENDED
-
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 ·Status: COMPLETED
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?
NCT03949946 ·Status: UNKNOWN
-
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
NCT06713161 ·Status: RECRUITING
-
Clinical Explorative Optical Breast Investigations
NCT06857669 ·Status: RECRUITING ·Phase: NA
-
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
NCT00610467 ·Status: TERMINATED ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968 ·Status: TERMINATED
-
MR Characterisation/Localisation of Breast Cancer
NCT01567137 ·Status: COMPLETED
-
A Study to Correlate Ultrasound Elastography With Histopathology to Monitor the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
NCT01737970 ·Status: COMPLETED
-
Fast Spectral Imaging Device for Tumor Margin Mapping
NCT01107080 ·Status: COMPLETED